Saturday, November 14, 2009

CDC issues new autism prevalence report - 7thSpace Interactive (press release)

KVOA.com

CDC issues new autism prevalence report 7thSpace Interactive (press release) “It is imperative that the federal government, primarily through the National Institutes of Health and CDC, quickly and significantly increase funding for ... US autism cases show 59% increase, alarming activists Study: 1 in 110 US children had autism in 2006

Healthcare Business News - ModernHealthcare.com

Healthcare Business News ModernHealthcare.com The NHIN work group is part of the Health Information Technology Policy Committee, an HHS federal advisory committee created pursuant to the stimulus law. ...

Texas agency slow to spend stimulus funds to weatherize homes - Dallas Morning News

Texas agency slow to spend stimulus funds to weatherize homes Dallas Morning News Daniel Araiza, a program monitor with the health department, said work using stimulus funds is under way on about 75 homes. Texas has a checkered past with ...

GlycoMimetics, Inc.: Series C $38M

GlycoMimetics (Gaithersburg, MD) a clinical-stage small molecule glycobiology company focused on cancer, inflammation and infectious disease, closed a $38M Series C financing. Participants include Genzyme Ventures, New Enterprise Associates, Novartis Venture Fund, Anthem Capital Management and Alliance Technology Ventures. A more detailed company profile recently appeared on Life Science Deal Flow [HERE].

Metabolon, Inc.: Series C $6M

Metabolon (Durham, NC) a metabolomics services and informatics company focused on detection of small molecule biomarkers, closed a $6M Series C financing, bringing the entire financing round to $12.3M. Participants include Syngenta Ventures, Fletcher Spaght Ventures, Sevin Rosen Funds, Aurora Funds, Harris and Harris Group, Fulcrum Financial Partners and Alexandria Equities.

Evolva, SA: Series B $27.5M

Evolva (Switzerland) a clinical-stage synthetic biology small molecule company focused on proteinuri kidney and cardiovascular disease, closed a $27,5M Series B financing. Participants include Wellington Partners Venture Capital, Aravis Venture Associates, Auriga Partners and Vinci Capital.

Direct Flow Medical, Inc.: Series C $40M

Direct Flow Medical (Santa Rosa, CA) a development-stage medical device company focused on a percutaneous aortic tissue valve prosthesis, closed a $40M Series C financing. Participants include Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.

Molecular Detection, Inc.: Series C $3.3M

Molecular Detection (Wayne, PA) a development-stage molecular diagnostics company focused on reat-time PCR of MRSA detection, closed a $3.3M Series C financing. Participants include MentorTech Ventures, Ben Franklin Technology Partners, Robin Hood Ventures and the Mid-Atlantic Angel Group.